Related Experiment Video
Updated: May 9, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later?
Adriana Della Pietra1, Andrew F Russo1,2,3
1Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, USA.
Introduction:
The past 5 years of success with calcitonin gene-related peptide (CGRP) based drugs has transformed migraine into a relatively treatable neurological disorder. There are now eight monoclonal antibodies and small-molecule receptor antagonists available for the acute and preventive treatment of migraine. However, while the drugs have been remarkably effective and safe so far, they do not work for everyone, and some adverse effects have become apparent.
Areas Covered:
We describe key developments with the CGRP therapeutics regarding real-world effectiveness and safety. Emerging evidence supporting combinatorial treatment strategies within the CGRP drugs and with onabotulinumtoxinA will be discussed.
Expert Opinion:
The future of peptides is bright for migraine therapeutics. A monoclonal antibody against pituitary adenylate cyclase-activating polypeptide (PACAP) has shown promise in two clinical trials and evidence suggests that CGRP and PACAP therapeutics may be complementary. A second CGRP receptor, AMY1, which is also activated by another peptide, amylin, is a new therapeutic target validated by clinical and preclinical data. Building on the CGRP story, centrally acting CGRP antagonists are an untapped area that should be explored. We close with a brief speculation on possible future applications of CGRP drugs for other disorders.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Analgesia and Pain Management
Direct-Acting Cholinergic Agonists: Therapeutic Uses

